Xiu-Yun Tian
Overview
Explore the profile of Xiu-Yun Tian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xue G, Li C, Lv A, Wu J, Tian X, Qiu H, et al.
Cancer Manag Res
. 2024 Aug;
16:1021-1030.
PMID: 39157713
Background: Extended surgery with multi-visceral resection is the standard treatment for retroperitoneal liposarcoma (RLPS). Malnutrition tends to result in increased surgical complications and reduced survival. The aim of this study...
2.
Liu D, Yan L, Li Z, Wang H, Tian X, Lv A, et al.
BMC Cancer
. 2024 Jul;
24(1):855.
PMID: 39026264
Background: Retroperitoneal liposarcoma (RLPS) constitutes the majority of retroperitoneal sarcomas. While surgical resection remains the sole curative approach, determining the optimal surgical strategy for RLPS remains elusive. This study addresses...
3.
Qian H, Wu Q, Wu J, Tian X, Xu W, Hao C
Mol Med Rep
. 2024 Mar;
29(4).
PMID: 38426568
Subsequently to the publication of the above article, an interested reader drew to the authors' attention that two pairs of data panels featured in Figs. 2E and 6D, portraying the...
4.
Liu D, Li C, Li H, Wang H, Tian X, Hao C
Abdom Radiol (NY)
. 2024 Jan;
49(3):958-963.
PMID: 38245900
Purpose: Desmoid tumor (DT) is a rare monoclonal, fibroblastic proliferation characterized by a variable and often unpredictable clinical course. Initial active surveillance is recommended by current guideline, and surgery is...
5.
Liu D, Wu J, Li Z, Wang H, Tian X, Hao C
BMC Med Imaging
. 2023 Dec;
23(1):215.
PMID: 38110909
Purpose: Retroperitoneal liposarcoma (RLPS) poses a challenging scenario for surgeons due to its unpredictable biological behavior. Surgery remains the primary curative option for RLPS; however, the need for additional information...
6.
Zhang M, Yang D, He Z, Wu Y, Tian X, Huang Q, et al.
Anticancer Drugs
. 2023 Aug;
35(2):129-139.
PMID: 37615540
Colorectal cancer (CRC) is one of the world's most common and deadly cancers. According to GLOBOCAN2020's global incidence rate and mortality estimates, CRC is the third main cause of cancer...
7.
Lv A, Liu D, Wang Z, Li C, Liu B, Liu Q, et al.
J Surg Oncol
. 2022 Nov;
127(4):633-644.
PMID: 36444482
Background And Objectives: Resection of retroperitoneal sarcoma (RPS) en bloc with pancreas is challenging and controversial. This single-center retrospective study aimed to analyze the impact of pancreatic resection (PR) and...
8.
Li Y, Wu J, Li C, Liu B, Tian X, Qiu H, et al.
Front Oncol
. 2022 Nov;
12:950418.
PMID: 36387243
Background: Peritoneal sarcomatosis (PS) could occur in patients with retroperitoneal sarcomas (RPS). This study aimed to expand the understanding of PS on its characteristics and prognostic role, and develop a...
9.
Wang Z, Wu J, Li C, Lv A, Qiu H, Tian X, et al.
Front Surg
. 2022 Sep;
9:956384.
PMID: 36157408
The outcomes of patients with primary retroperitoneal sarcoma (RPS) are significantly superior to those with recurrence. resection of tumor and adjacent organs is recommended in primary RPS. However, whether resection...
10.
Lv A, Li Y, Li Z, Mao L, Tian X, Hao C
J Surg Oncol
. 2022 Aug;
126(7):1288-1298.
PMID: 35943840
Background And Objectives: Retroperitoneal sarcomas (RPSs) are difficult to manage, rare malignant tumors. This single-center, retrospective study aimed to analyze the treatment algorithm and outcomes of aggressive surgical treatment in...